These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24290306)

  • 21. Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Senda N; Miyagaki T; Oka T; Itoigawa A; Kikuchi K; Kobayashi T; Nakamura F; Kurokawa M; Sugaya M; Sato S
    J Dermatol; 2019 May; 46(5):e161-e163. PubMed ID: 30379350
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma.
    Morrison JA; Gulley ML; Pathmanathan R; Raab-Traub N
    Cancer Res; 2004 Aug; 64(15):5251-60. PubMed ID: 15289331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.
    Luo WJ; He SW; Zou WQ; Zhao Y; He QM; Yang XJ; Guo R; Mao YP
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2618-2629. PubMed ID: 34424090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent occurrence of primary intracranial Epstein-Barr virus-associated leiomyosarcoma and Hodgkin lymphoma in a young adult.
    Takei H; Powell S; Rivera A
    J Neurosurg; 2013 Aug; 119(2):499-503. PubMed ID: 23621602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential occurrence of diffuse large B-cell lymphoma and carcinoma in the nasopharynx: A case report.
    Hong YT; Hong KH
    Medicine (Baltimore); 2018 Jan; 97(2):e9595. PubMed ID: 29480859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential.
    Cheung FM; Pang SW; Yau TK; Chow SK; Lo KW
    Histopathology; 2004 Aug; 45(2):171-9. PubMed ID: 15279636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.
    Chan KC; Zhang J; Chan AT; Lei KI; Leung SF; Chan LY; Chow KC; Lo YM
    Cancer Res; 2003 May; 63(9):2028-32. PubMed ID: 12727814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.
    Adham M; Greijer AE; Verkuijlen SA; Juwana H; Fleig S; Rachmadi L; Malik O; Kurniawan AN; Roezin A; Gondhowiardjo S; Atmakusumah D; Stevens SJ; Hermani B; Tan IB; Middeldorp JM
    Clin Cancer Res; 2013 Apr; 19(8):2175-86. PubMed ID: 23493345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization.
    Akao I; Sato Y; Mukai K; Uhara H; Furuya S; Hoshikawa T; Shimosato Y; Takeyama I
    Laryngoscope; 1991 Mar; 101(3):279-83. PubMed ID: 1847985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
    Huang Q; Wilczynski SP; Chang KL; Weiss LM
    Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
    Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W
    Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for EBV-associated malignancies.
    Merlo A; Turrini R; Dolcetti R; Zanovello P; Rosato A
    Int J Hematol; 2011 Mar; 93(3):281-293. PubMed ID: 21336546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen.
    Sugden B
    PLoS Biol; 2014 Sep; 12(9):e1001939. PubMed ID: 25180782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
    Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
    Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.